EMA requests more data from GLP-1 drugmakers in suicidal ideation, self-harm probe (2023) Available from Accessed 7 April 2024 Ruggiero R, Mascolo A, Spezzaferri A, Carpentieri C, Torella D, Sportiello L (2024) Glucagon-like peptide-1 receptor agonists and suicidal ideation: analysis of real-word data collected in the European pharmacovigilance database
C., Maulik, G., Christensen, J
Some drugmakers offer copay cards or assistance programs for eligible people
Tirzepatides cardiovascular benefits are still being studied, but early data suggests it offers similar protections
We tend to think of weight gain as a simple equation and one which can be solved by manipulating the number of calories that we consume and the amount that we burn
Yes, switching between semaglutide pills and injections is possiblebut it should always be done under medical supervision